Author response: Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population
Abstract
Metabolic biomarkers measured from single blood test can identify apparently healthy people at high susceptibility for developing severe pneumonia, and may also be useful for preventive COVID-19 screening.
Authors 4
-
Affiliation as printed
Nightingale Health Plc
-
Affiliation as printed
Nightingale Health Plc
-
Leiden University Medical Center · Max Planck Institute for Biology of Ageing
Affiliation as printed
Max Planck Institute for Biology of Ageing
Molecular Epidemiology, Department of Biomedical Data Sciences, Leiden University Medical Center
-
Affiliation as printed
Nightingale Health Plc
Cited by 1 stored of 1
1 result
No patents citing this paper on Lens.org (checked 2026-10-11).